Efficacy of topical mesenchymal stem cell therapy in the treatment of experimental dry eye syndrome model

Stem Cells International

Volumn 2014, Issue , 2014, Pages

  Beyazyildiz, Emrullah ^a   Pinarli, Ferda Alpaslan ^b   Beyazyildiz, Özlem ^a   Hekimoʇlu, Emine Rümeysa ^c   Acar, Uʇur ^c   Demir, Muhammed Necati ^d   Albayrak, Aynur ^e   Kaymaz, Figen ^c   Sobaci, Güngör ^c   Delibaşi, Tuncay ^c  

^a Department of Ophthalmology Samsun Research and Training Hospital ^*  (Turkey)

^b Diskapi Yildirim Beyazid Education and Research Hospital   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

^e DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BENZALKONIUM CHLORIDE; BROXURIDINE; EYE DROPS; PHOSPHATE BUFFERED SALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAK UP TIME SCORE; CELL COUNT; CELL INFILTRATION; CELL LABELING; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORNEAL INFLAMMATORY INDEX SCORING TEST; DRY EYE; ELECTRON MICROSCOPY; GOBLET CELL; HISTOPATHOLOGY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OCULAR SURFACE EVALUATION TEST; PRIORITY JOURNAL; RAT; SAFETY; SCHIRMER TEST; SECRETORY GRANULE; TEAR FLOW; TREATMENT DURATION; TREATMENT RESPONSE; VISUAL SYSTEM EXAMINATION; VISUAL SYSTEM PARAMETERS;

MEIBOMIA; RATTUS;

EID: 84935003084     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2014/250230     Document Type: Article

References (28)

1. "The definition and classification of dry eye disease: Report of the definition and classification subcommittee of the International Dry Eye WorkShop (2007)," The Ocular Surface, vol. 5, no. 2, pp. 75-92, 2007.
2. T. J. Nagelhout, D. A. Gamache, L. Roberts, M. T. Brady, and J. M. Yanni, "Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye," Journal of Ocular Pharmacology andTherapeutics, vol. 21, no. 2, pp. 139-148, 2005.
3. D. Zoukhri, "Mechanisms involved in injury and repair of the murine lacrimal gland: role of programmed cell death and mesenchymal stem cells," Ocular Surface, vol. 8, no. 2,pp. 60-69, 2010.
4. B. Parekkadan and J. M. Milwid, "Mesenchymal stem cells as therapeutics," Annual Review of Biomedical Engineering, vol. 12, pp. 87-117, 2010.
5. L. A. Ortiz, F. Gambelli, C. McBride et al., "Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8407-8411, 2003.
6. M. Rojas, J. Xu, C. R. Woods et al., "Bone marrow-derived mesenchymal stemcells in repair of the injured lung," American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 2, pp. 145-152, 2005.
7. F. A. Pnarl?, N. N. Turan, F. Güçlü Pnarl? et al., "Resveratrol and adipose-derived mesenchymal stem cells are effective in the prevention and treatment of doxorubicin cardiotoxicity in rats," PediatricHematology-Oncology, vol. 30,no. 3, pp.226-238,2013.
8. S. Bilen, F. Pinarli, F. Ak et al., "Treatment efficacy with bone marrow derived mesenchymal stem cells and minocycline in rats after cerebral ischemic injury," Stem Cell Reviews and Reports, vol. 9, no. 2, pp. 219-225, 2013.
9. C. Xiong, D. Chen, J. Liu et al., "A rabbit dry eyemodel induced by topicalmedication of a preservative benzalkonium chloride," Investigative Ophthalmology and Visual Science, vol. 49, no. 5, pp. 1850-1856, 2008.
10. Z. Lin, X. Liu, T. Zhou et al., "A mouse dry eye model induced by topical administration of benzalkonium chloride,"Molecular Vision, vol. 25, no. 17, pp. 257-264, 2011.
11. L. Ma, W. Scheers, and P. Vandenberghe, "A flow cytometric method for determination of absolute counts of myeloid precursor dendritic cells in peripheral blood," Journal of Immunological Methods, vol. 285, no. 2, pp. 215-221, 2004.
12. A. Pauly, F. Brignole-Baudoin, A. Labbe et al., "New tools for the evaluation of toxic ocular surface changes in the rat," Investigative Ophthalmology & Visual Science, vol. 48, no. 12, pp. 473-483, 2007.
13. O. P. van Bijssterveld, "Diagnostic tests in the Sicca syndrome," Archives of Ophthalmology, vol. 82, no. 1, pp. 10-14, 1969.
14. C. Laria, J. L. Alió, and J. M. Ruiz-Moreno, "Combined nonsteroidal therapy in experimental corneal injury," Ophthalmic Research, vol. 29, no. 3, pp. 145-153, 1997.
15. L. M. Brennan, E. M. Boncavage-Hennessey, M. J. Wolfe et al., "An in vivomethod for using 5-bromo-2-deoxyuridine (BrdU) as a marker of chemically-induced hepatocellular proliferation in the Japanese medaka (Oryzias latipes)," Toxicologic Pathology, vol. 29, no. 3, pp. 387-397, 2001.
16. S. Tatapudy, S. Bruening, G. Gleason et al., "Validation and use of a computer assisted counting procedure to quantify BrdU-labeled proliferating cells in the early postnatal mouse hippocampus," Journal of Neuroscience Methods, vol. 172, no. 2, pp. 173-177, 2008.
17. E. McCabe and S. Narayanan, "Advancements in anti-inflammatory therapy for dry eye syndrome," Optometry, vol. 80, no. 10, pp. 555-566, 2009.
18. C. Baudouin, "The pathology of dry eye," Survey of Ophthalmology, vol. 45, no. 2, pp. S211-S220, 2001.
19. L. Yao and H. Bai, "Review: mesenchymal stem cells and corneal reconstruction," Molecular Vision, vol. 19, pp. 2237-2243, 2013.
20. H. Yagi, A. Soto-Gutierrez, B. Parekkadan et al., "Mesenchymal stem cells: mechanisms of immunomodulation and homing," Cell Transplantation, vol. 19, no. 6-7, pp. 667-679, 2010.
21. Y. Ma, Y. Xu, Z. Xiao et al., "Reconstruction of chemically burned rat corneal surface by bone marrow-derived human mesenchymal stem cells," Stem Cells, vol. 24, no. 2, pp. 315-321, 2006.
22. L. Yao, Z. R. Li, W. R. Su et al., "Role ofmesenchymal stem cells on cornea wound healing induced by acute alkali burn," PLoS ONE, vol. 7, no. 2,Article ID e30842, 2012.
23. T. Guo, W. Wang, J. Zhang, X. Chen, B. Li, and L. Li, "Experimental study on repairing damage of corneal surface by mesenchymal stemcells transplantation," Yan Ke Za Zhi, vol. 42, no. 3, pp. 246-250, 2006.
24. J. Ye, K. Yao, and J. C. Kim, "Mesenchymal stem cell transplantation in a rabbit corneal alkali burn model: engraftment and involvement in wound healing," Eye, vol. 20, no. 4, pp. 482-490, 2006.
25. A. Gallazzi, E. Ghinelli, and G. Carito, "Topical application of BMderived stem cells enhances the repair of corneal injuries," Investigative Ophthalmology & Visual Science, vol. 45, 2004.
26. G. I. Agorogiannis, V.-I. Alexaki, O. Castana, and G. D. Kymionis, "Topical application of autologous adipose-derived mesenchymal stem cells (MSCs) for persistent sterile corneal epithelial defect," Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 250, no. 3, pp. 455-457, 2012.
27. A.W. Joe and K. Gregory-Evans, "Mesenchymal stem cells and potential applications in treating ocular disease," Current Eye Research, vol. 35, no. 11, pp. 941-952, 2010.
28. J. Xu, D. Wang, D. Liu et al., "Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome," Blood, vol. 120, no. 15, pp. 3142-3151, 2012.